Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Immuron Ltd ADR stock
Learn how to easily invest in Immuron Ltd ADR stock.
Immuron Ltd ADR is a biotechnology business based in the US. Immuron Ltd ADR shares (IMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Immuron Ltd ADR employs 5 staff and has a trailing 12-month revenue of around $765,193.
How to buy Immuron Ltd ADR stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – IMRN. It's that simple.
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- Get $10 when you sign up and deposit $100
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Immuron Ltd ADR stock price (NASDAQ: IMRN)Use our graph to track the performance of IMRN stocks over time.
Immuron Ltd ADR shares at a glance
|Latest market close||$2.23|
|52-week range||$1.39 - $4.27|
|50-day moving average||$2.02|
|200-day moving average||$2.40|
|Wall St. target price||$6.41|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.56|
Buy Immuron Ltd ADR stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Immuron Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Immuron Ltd ADR price performance over time
|1 week (2023-01-19)||4.71%|
|1 month (2022-12-23)||16.49%|
|3 months (2022-10-26)||15.89%|
|6 months (2022-07-26)||-6.51%|
|1 year (2022-01-26)||-39.70%|
|2 years (2021-01-26)||-70.49%|
|3 years (2020-01-23)||3.46|
|5 years (2018-01-26)||6.73|
Immuron Ltd ADR financials
|Gross profit TTM||$523,502|
|Return on assets TTM||-7.51%|
|Return on equity TTM||-11.63%|
|Market capitalisation||$12.3 million|
TTM: trailing 12 months
Immuron Ltd ADR share dividends
We're not expecting Immuron Ltd ADR to pay a dividend over the next 12 months.
Immuron Ltd ADR share price volatility
Over the last 12 months, Immuron Ltd ADR's shares have ranged in value from as little as $1.39 up to $4.265. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immuron Ltd ADR's is 1.3318. This would suggest that Immuron Ltd ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Immuron Ltd ADR overview
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III registration trial to reduce the risk of contracting travelers' diarrhea in the United States, and Phase II field trial for Travelers' Diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in Phase I/IIa clinical trial for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. .
Immuron Ltd ADR in the news
Immuron US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease
Frequently asked questionsWhat percentage of Immuron Ltd ADR is owned by institutions?
Currently 0.332% of Immuron Ltd ADR shares are held by institutions. How many people work for Immuron Ltd ADR?
Latest data suggests 5 work at Immuron Ltd ADR. When does the fiscal year end for Immuron Ltd ADR?
Immuron Ltd ADR's fiscal year ends in June. Where is Immuron Ltd ADR based?
Immuron Ltd ADR's address is: 62 Lygon Street, Carlton, VIC, Australia, 3053 What is Immuron Ltd ADR's ISIN number?
Immuron Ltd ADR's international securities identification number is: US45254U1016 What is Immuron Ltd ADR's CUSIP number?
Immuron Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 45254U101
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert